Register to leave comments

  • News bot Aug. 14, 2026, 12:02 p.m.

    📋 OUTLOOK THERAPEUTICS, INC. (OTLK) - Financial Results

    Filing Date: 2026-08-14

    Accepted: 2026-08-14 08:00:49

    Event Type: Financial Results

    Event Details:

    OUTLOOK THERAPEUTICS, INC. (OTLK) Reports the reporting period Financial Results OUTLOOK THERAPEUTICS, INC. (OTLK) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 17
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 11242
      • targeting strategy to prioritize retina practices with the greatest potential for early adoption and is building its commercial team with experienced leaders with deep expertise in retina, product launches, and the increasingly competitive and complex wet AMD and anti-VEGF market. The Company’s launch and go-to-market strategy is designed to reflect the evolving biosimilar landscape, affordability considerations, and the potential for additional market entrants, while supporting broad patient access and reimbursement. As part of these efforts, the Company plans to submit an application for a permanent Healthcare Common Procedure Coding System or HCPCS code by October 1, 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Selling General Administrative 9.68K 25.67K $-15.99K -62.29%
    Operating Expenses Loss From Operations 15.75K 38.32K $-22.57K -58.90%
    Operating Expenses Interest Expense 49.00 49.00 $0.00 +0.00%
    Income Tax Expense Net Loss 20.15K 47.83K $-27.68K -57.87%
    Revenue 1.50K 1.07K $434.00 +40.52%
    Selling, General & Administrative 9.68K 25.67K $-15.99K -62.29%
    Loss from Operations 15.75K 38.32K $-22.57K -58.90%
    Interest Expense 49.00 49.00 $0.00 +0.00%
    Net Loss 20.15K 47.83K $-27.68K -57.87%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: OUTLOOK THERAPEUTICS, INC.
    • Ticker Symbol: OTLK